As part of the settlement, CVS admitted and accepted responsibility for certain conduct alleged by the government, including ...

For a decade, CVS knew it was skirting rules meant to limit overprescribing but did nothing to stop, according to the ...

CVS settles insulin dispensing case for $38M over improper billing to Medicare, Medicaid and federal health programs from 2010 to 2020.

Despite its small base, rapid growth in smart insulin administration, connected devices, patient-centric care, and home-based ...

Q4 2025 Earnings Call Transcript November 25, 2025 Embecta Corp. misses on earnings expectations. Reported EPS is $ EPS, ...

According to DataM Intelligence, the Insulin Delivery Devices Market Size reached USD 20.26 billion in 2024 and is projected ...

A new polymer reported in Nature may mark a turning point for needle-free insulin delivery. Researchers at Zhejiang University have developed a charge-shifting polyzwitterion that can carry insulin ...

According to Precedence Research, the global tubeless insulin pump market size will grow from USD 2.92 billion in 2025 to nearly USD 13.65 billion by 2034, with an expected CAGR of 18.74% from 2025 to ...

In mice with type 1 diabetes, a topical dose of OP-I was smeared onto the skin. Blood glucose levels fell to a normal range ...

A groundbreaking polymer-based skin cream shows promise in replacing painful daily insulin injections for diabetes management ...

Master your insulin routine with essential dos and don'ts for safe, effective diabetes management. Learn about proper injection sites, timing, storage, and more.

Corp., a large manufacturer of insulin injection devices, has expanded its partnership with Direct Relief, a leading humanitarian aid organization and large charitable insulin provider in the ...